CI Monitoring Support

One of the top 20 biopharmaceutical company, focused on multiple indications was looking to actively monitor its IBD space and stay abreast with the latest market trends and competition.

Leveraging a traditional approach of manual tracking & assessment brought several hurdles with itself, such as

• Effort intensive exercise to scout through relevant sources available in public domain, and derive key insights
• Lack of client-relevant insights available in an easy-to-consume manner
• Unavailability of customization options to slice & dice data insights as per client’s requirements

Therefore, the client was looking for innovative solutions to help understand & monitor the development & other activities in the IBD space, in a holistic & time-efficient manner. This included basic landscape analysis encompassing the following elements

• Clinical landscape of pipeline and approved products
• Event Analysis – Keeping abreast with the current news events, anticipating future events via expected approval timelines, and clinical trial tracking
• Data Management: An automated approach which can serve as a one-stop shop for managing all the data

Additionally, the client was also hoping to overcome the following business challenges, which plagues every Insights team

• Knowledge management: Efficiency in receiving, storing and retrieving relevant information
• Visualization: Real-time updates of events which will also offer visualization & predictive insights
• Team Collaboration: Collaborative execution of reports between the team members

Understanding the client requirement for smart automation & customizations, DataZymes team developed an AI-enabled CI Solution, integrating deep industry knowledge, advanced analytics, and human centric design, to help the client stay current on the business developments in their market of interest.

The team adopted an AI-based ‘Human and Technology’ approach to increase the efficiency of data collection & insight generation using automation

• Automated data extraction to map the molecules, events, and trials in the IBD market for CD and UC indications
• Worked closely with the Tableau team to design an AI-enabled CI tool that includes all the proposed modules

The DataZymes team was able to offer a complete package of six key dashboards to cater to the client needs on analysis of the IBD market including Crohn’s Disease and Ulcerative Colitis–

• Landscape: Provides a bird’s eye view of all the in-line and pipeline therapies in a selected indication
• News Events: Latest updates for any molecule including regulatory, commercial, or clinical developments
• Approval Timelines: An estimated or communicated approval date of a pipeline molecule
• Clinical Program: All the listed Phase III and Phase II clinical trials
• Company Profile: A quick snapshot of company and its origin, previous year sales
• Product Profile: Sales by geography, mechanism of action, promotional material, and indications